Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biocartis financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€0.3
2024-10-29
Market Capitalization
€27.2 M
2024-10-29
Revenue
€47.4 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|
| Revenue | 27.8M | 37.4M | 43.1M | 48.3M | 57.5M | 47.4M |
| Cost of goods sold | 9.5M | 13.5M | 16.4M | 20.0M | 17.0M | 12.4M |
| Gross profit | 19.2M | 24.2M | 39.1M | 34.9M | 41.0M | 35.3M |
| Gross profit margin, % | 69.0% | 64.7% | 90.7% | 72.3% | 71.4% | 74.4% |
| Operating expense total | 58.2M | 69.8M | 75.8M | 87.4M | 77.3M | 63.3M |
| Depreciation and amortization | 7.8M | 9.7M | 9.7M | 9.8M | 10.5M | 10.0M |
| EBITDA | (39.0M) | (46.3M) | (37.2M) | (53.1M) | (37.2M) | (28.7M) |
| EBITDA margin, % | -140.2% | -123.5% | -86.2% | -110.0% | -64.6% | -60.6% |
| EBIT | (46.8M) | (56.0M) | (46.9M) | (63.0M) | (47.6M) | (38.7M) |
| EBIT margin, % | -168.3% | -149.5% | -108.8% | -130.4% | -82.9% | -81.8% |
| Interest income | 163.0K | |||||
| Interest expense | 1.6M | 7.9M | 15.8M | 9.5M | 17.7M | 70.2M |
| Pre tax profit | (48.3M) | (64.2M) | (63.2M) | (71.7M) | (65.6M) | 18.2M |
| Income tax expense | (109.0K) | (99.0K) | (228.0K) | (243.0K) | (240.0K) | (170.0K) |
| Net Income | (48.2M) | (64.1M) | (62.9M) | (71.5M) | (65.4M) | 18.4M |